Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M307223200 on September 21, 2003

J. Biol. Chem., Vol. 278, Issue 48, 47724-47730, November 28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/48/47724    most recent
M307223200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sommer, U.
Right arrow Articles by Doering, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, U.
Right arrow Articles by Doering, T. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

An {alpha}-1,3-Mannosyltransferase of Cryptococcus neoformans*

Ulf Sommer{ddagger}, Hong Liu, and Tamara L. Doering§

From the Department of Molecular Microbiology, Washington University Medical School, St. Louis, Missouri 63110

Cryptococcus neoformans is a pathogenic fungus, distinguished by an elaborate polysaccharide capsule that is essential for its virulence. As part of an effort to understand the biosynthesis of this important structure, we initiated purification of an {alpha}-1,3-mannosyltransferase with appropriate specificity for a role in building the main capsule polysaccharide, glucuronoxylomannan. A pool of proteins that was 5,000-fold enriched in this activity included several polypeptides, which acted potentially as the catalytic protein. These were analyzed using sequence information and double-stranded RNA interference. Interference that targeted a sequence corresponding to part of a 46 kDa protein in the enriched fraction abolished the activity of interest and reduced the capsule on the affected cells. This gene was cloned and expressed in active form in Saccharomyces cerevisiae to confirm function, and was termed CMT1, for cryptococcal mannosyltransferase 1. CMT1 has no confirmed homologs in GenBankTM other than CAP59, a cryptococcal gene encoding a protein of unknown function that is required for capsule synthesis and virulence. The Cmt1p protein also co-purifies with a homolog of CAP64, a gene whose product has similarly been implicated in capsule synthesis and virulence. A strain disrupted in CMT1 was generated in C. neoformans; this had no effect on virulence in an animal model of cryptococcosis.


Received for publication, July 7, 2003 , and in revised form, September 11, 2003.

* This work was supported by National Institutes of Health Grant R01 AI49173 and a GRANT Award from Neose Technologies, and the Andrew and Virginia Craig Faculty Research Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Current address: Mass Spectrometry Resource, Boston University School of Medicine, Boston, MA.

§ A Burroughs Wellcome Fund Junior Investigator in Molecular Pathogenic Mycology. To whom correspondence should be addressed: Campus Box 8230, 660 South Euclid Ave., St. Louis, MO 63110-1093. Tel.: 314-747-5597; Fax: 314-362-1232; E-mail: doering{at}borcim.wustl.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. S. Klutts and T. L. Doering
Cryptococcal Xylosyltransferase 1 (Cxt1p) from Cryptococcus neoformans Plays a Direct Role in the Synthesis of Capsule Polysaccharides
J. Biol. Chem., May 23, 2008; 283(21): 14327 - 14334.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
T. Krajaejun, G. M. Gauthier, C. A. Rappleye, T. D. Sullivan, and B. S. Klein
Development and Application of a Green Fluorescent Protein Sentinel System for Identification of RNA Interference in Blastomyces dermatitidis Illuminates the Role of Septin in Morphogenesis and Sporulation
Eukaryot. Cell, August 1, 2007; 6(8): 1299 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
A. Jong, C.-H. Wu, H.-M. Chen, F. Luo, K. J. Kwon-Chung, Y. C. Chang, C. W. LaMunyon, A. Plaas, and S.-H. Huang
Identification and Characterization of CPS1 as a Hyaluronic Acid Synthase Contributing to the Pathogenesis of Cryptococcus neoformans Infection
Eukaryot. Cell, August 1, 2007; 6(8): 1486 - 1496.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Klutts, S. B. Levery, and T. L. Doering
A beta-1,2-Xylosyltransferase from Cryptococcus neoformans Defines a New Family of Glycosyltransferases
J. Biol. Chem., June 15, 2007; 282(24): 17890 - 17899.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
A. L. Gutierrez, L. Farage, M. N Melo, R. S Mohana-Borges, Y. Guerardel, B. Coddeville, J.-M. Wieruszeski, L. Mendonca-Previato, and J. O Previato
Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans
Glycobiology, June 1, 2007; 17(6): 1C - 1C.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
T. R. Cottrell, C. L. Griffith, H. Liu, A. A. Nenninger, and T. L. Doering
The Pathogenic Fungus Cryptococcus neoformans Expresses Two Functional GDP-Mannose Transporters with Distinct Expression Patterns and Roles in Capsule Synthesis
Eukaryot. Cell, May 1, 2007; 6(5): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
O. W. Liu, M. J. S. Kelly, E. D. Chow, and H. D. Madhani
Parallel {beta}-Helix Proteins Required for Accurate Capsule Polysaccharide Synthesis and Virulence in the Yeast Cryptococcus neoformans
Eukaryot. Cell, April 1, 2007; 6(4): 630 - 640.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. C. Chang, A. Jong, S. Huang, P. Zerfas, and K. J. Kwon-Chung
CPS1, a Homolog of the Streptococcus pneumoniae Type 3 Polysaccharide Synthase Gene, Is Important for the Pathobiology of Cryptococcus neoformans
Infect. Immun., July 1, 2006; 74(7): 3930 - 3938.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Griffith, J. S. Klutts, L. Zhang, S. B. Levery, and T. L. Doering
UDP-glucose Dehydrogenase Plays Multiple Roles in the Biology of the Pathogenic Fungus Cryptococcus neoformans
J. Biol. Chem., December 3, 2004; 279(49): 51669 - 51676.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
F. Moyrand, Y. C. Chang, U. Himmelreich, K. J. Kwon-Chung, and G. Janbon
Cas3p Belongs to a Seven-Member Family of Capsule Structure Designer Proteins
Eukaryot. Cell, December 1, 2004; 3(6): 1513 - 1524.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
F. Moyrand and G. Janbon
UGD1, Encoding the Cryptococcus neoformans UDP-Glucose Dehydrogenase, Is Essential for Growth at 37{degrees}C and for Capsule Biosynthesis
Eukaryot. Cell, December 1, 2004; 3(6): 1601 - 1608.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement